These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6146037)

  • 1. Role of a single haemopoietic growth factor in multiple proliferative disorders of haemopoietic and related cells.
    Schrader JW
    Lancet; 1984 Jul; 2(8395):133-7. PubMed ID: 6146037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells.
    Schrader JW; Crapper RM
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6892-6. PubMed ID: 6417657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of haemopoietic cell growth factor (interleukin 3) in the development of haemopoietic cells.
    Dexter TM; Heyworth CM; Whetton AD
    Ciba Found Symp; 1985; 116():129-47. PubMed ID: 3935399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo models for studying the role of autocrine or paracrine growth factors in hematologic malignancies.
    Soma T; Dunbar CE
    Exp Hematol; 1995 May; 23(5):385-8. PubMed ID: 7720810
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of haemopoietic growth factor to lymphocytes and interleukin 3: a short review.
    Garland JM; Dexter TM
    Lymphokine Res; 1983; 2(1):13-22. PubMed ID: 6433116
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors affecting the growth and differentiation of haemopoietic cells in culture.
    Stanley ER; Jubinsky PT
    Clin Haematol; 1984 Jun; 13(2):329-48. PubMed ID: 6088143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemopoietic growth factor control of normal and neoplastic cellular proliferation.
    Burgess AW; Cebon J; Smith S
    Biochem Soc Symp; 1989; 55():57-68. PubMed ID: 2695090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukaemia: development, remission/relapse pattern, relationship between normal and leukaemic haemopoiesis, and the 'sleeper-to-feeder' stem cell hypothesis.
    Killmann SA
    Baillieres Clin Haematol; 1991 Jul; 4(3):577-98. PubMed ID: 1958881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro approaches to lymphopoiesis, hemopoiesis, and oncogenesis.
    Schrader JW; Schrader S; Clark-Lewis I; Crapper R
    Kroc Found Ser; 1984; 18():293-307. PubMed ID: 6152287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid neoplasia and the control of haemopoietic differentiation.
    Adams JM; Harris AW; Langdon WY; Klinken SP; Kongsuwan K; Alexander WS; Hariharan I; Vaux D; Rosenbaum H; Crawford M
    Ciba Found Symp; 1989; 142():54-64; discussion 65-70. PubMed ID: 2568245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristics.
    Heyworth CM; Gagen D; Edington KG; Fairbairn LJ
    Leukemia; 2002 Jan; 16(1):106-11. PubMed ID: 11840269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mutant c-Kit in early myeloid cells.
    Ashman LK; Ferrao P; Cole SR; Cambareri AC
    Leuk Lymphoma; 1999 Aug; 34(5-6):451-61. PubMed ID: 10492068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of cell markers in the study of human hematopoietic neoplasia.
    Raskind WH; Fialkow PJ
    Adv Cancer Res; 1987; 49():127-67. PubMed ID: 2890277
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for the in vivo production and release into the serum of a T-cell lymphokine, persisting-cell stimulating factor (PSF), during graft-versus-host reactions.
    Crapper RM; Schrader JW
    Immunology; 1986 Apr; 57(4):553-8. PubMed ID: 3082748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 3-dependent hematopoietic progenitor cell lines.
    Greenberger JS; Eckner RJ; Sakakeeny M; Marks P; Reid D; Nabel G; Hapel A; Ihle JN; Humphries KC
    Fed Proc; 1983 Jul; 42(10):2762-71. PubMed ID: 6305732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemopoietic growth factors and leukaemogenesis.
    Pierce A; Whetton AD
    Biochem Soc Trans; 1997 May; 25(2):366-70. PubMed ID: 9191119
    [No Abstract]   [Full Text] [Related]  

  • 18. p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.
    Pierce A; Owen-Lynch PJ; Spooncer E; Dexter TM; Whetton AD
    Oncogene; 1998 Aug; 17(5):667-72. PubMed ID: 9704934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and partial purification of a haemopoietic cell growth factor in WEHI-3 cell conditioned medium.
    Bazill GW; Haynes M; Garland J; Dexter TM
    Biochem J; 1983 Mar; 210(3):747-59. PubMed ID: 6575777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.
    Schwaller J; Frantsve J; Aster J; Williams IR; Tomasson MH; Ross TS; Peeters P; Van Rompaey L; Van Etten RA; Ilaria R; Marynen P; Gilliland DG
    EMBO J; 1998 Sep; 17(18):5321-33. PubMed ID: 9736611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.